ampicillin has been researched along with isoniazid in 50 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 11 (22.00) | 18.7374 |
1990's | 1 (2.00) | 18.2507 |
2000's | 3 (6.00) | 29.6817 |
2010's | 33 (66.00) | 24.3611 |
2020's | 2 (4.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Gaillard, JL; Jackson, M; McDonnell, G; Niederweis, M; Skovierová, H; Svetlíková, Z | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Chiba, T; Hasegawa, T; Horita, Y; Kremer, L; Kuroishi, R; Lee, Y; Ogawa, K; Onozaki, K; Sato, Y; Takii, T | 1 |
Aoki, S; Arevalo, S; Izumizono, Y; Koseki, Y; Kuroki, M | 1 |
Mungra, DC; Patel, MP; Patel, RG; Rajani, DP | 1 |
Akhaja, TN; Raval, JP | 1 |
Chen, L; Franzblau, SG; Liu, X; Lu, X; Wan, B; You, Q; Zhou, C | 1 |
Barad, HA; Gupta, VK; Kant, R; Pansuriya, BR; Parmar, NJ | 1 |
Patel, MP; Patel, RG; Shah, NM | 1 |
Bonifácio, VD; Gawande, MB; Mhaske, GR; Shelke, SN | 1 |
Parmar, BD; Parmar, NJ; Patel, RA; Talpada, NP | 1 |
Kathrotiya, HG; Patel, MP | 1 |
Jardosh, HH; Patel, MP | 1 |
Cížek, A; Imramovský, A; Jampílek, J; Masaříková, M; Pauk, K; Pokorná, M; Vinšová, J; Zadražilová, I | 1 |
Cai, G; Cho, S; Franzblau, SG; Jaki, BU; Lee, IA; McAlpine, JB; Napolitano, JG; Pauli, GF; Suh, JW; Wang, Y; Yang, SH | 1 |
Kalaria, PN; Raval, DK; Satasia, SP | 1 |
Anand, N; Chaturvedi, V; Dwivedi, AK; Gupt, MP; Gupta, V; Kumar, B; Lal, J; Pandey, S; Pandey, SK; Rai, N; Ramachandran, R; Ramakrishna, KK; Sharma, P; Shukla, PK; Singh, S; Srivastava, KK; Tripathi, RP | 1 |
Avalani, JR; Kalaria, PN; Raval, DK; Satasia, SP | 1 |
Karad, SC; Purohit, VB; Raval, DK | 1 |
Inturi, B; Mohan Krishna, K; Pujar, GV; Purohit, MN; Vijaykumar, GS | 1 |
Alam, MZ; Bruhn, DF; Feng, L; Hurdle, JG; Lee, RB; Lee, RE; Maddox, MM; Narula, G; Sandhaus, S; Simmons, CJ; Sun, D; Tse-Dinh, YC; Tsutsumi, LS; Wu, X | 1 |
Karad, SC; Purohit, VB; Raval, DK; Thakkar, VR; Thakor, P | 1 |
Bhatt, K; Desai, NC; Jha, PC; Khedkar, VM; Nawale, L; Sarkar, D; Somani, H; Trivedi, A | 1 |
Arkile, MA; Sarkar, D; Shaikh, MH; Shingate, BB; Subhedar, DD; Yeware, A | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Sankar, C; Umamatheswari, S | 1 |
Andrade, CH; Braga, RC; Cho, S; Franzblau, SG; Gomes, MN; Grzelak, EM; Klein, LL; Ma, R; Muratov, E; Neves, BJ; Oliveira, GR | 1 |
Abdel-Aziz, MM; Abdelrahman, MA; Elaasser, MM; Gomaa, MS; Salama, I; Soliman, DH | 1 |
Bernardino, AMR; Boechat, N; Dos Santos, MS; Faria, JV; Miguita, AGC; Vegi, PF | 1 |
De Coen, LM; Gemili, M; Nural, Y; Sahin, E; Sari, H; Ulger, M | 1 |
Bai, L; Deng, J; Feng, L; Lv, Z; Wang, Y; Xu, Z; Zhang, F; Zhao, S | 1 |
Daraji, DG; Jayanthi, S; Patel, HD; Pithawala, EA; Rajani, DP; Rajani, SD | 1 |
Beech, J | 1 |
Atkinson, B; Lorian, V | 1 |
Gikalov, I; Hoigné, R; Keller, M; Klein, U | 1 |
Houde, M; Laplante, L | 1 |
Warren, WP; Woolf, CR | 1 |
Anderson, KA; Guzzetti, PJ; Peritore, SP; Rosenberg, JM | 1 |
Brihaye, J; Klastersky, J | 1 |
Evans, P; Reisinger, KS; Rogers, KD; Yost, G | 1 |
Katowitz, JA; Kay, ML; Yanoff, M | 1 |
Echikson, AB; Zauber, NP | 1 |
Herbert, D; Kubendiran, G; Mitchison, DA; Paramasivan, CN; Prabhakar, R; Venkatesan, P | 1 |
Bąk, A; Čížek, A; Goněc, T; Jampílek, J; Jendrzejewska, I; Kapustíková, I; Kollár, P; Kozik, V; Michnová, H; Musioł, R; Pospíšilová, Š; Trávníček, Z; Vančo, J | 1 |
Cizek, A; Hosek, J; Imramovsky, A; Jampilek, J; Magar, P; Michnova, H; Pauk, K; Pilarova, E; Pindjakova, D | 1 |
5 review(s) available for ampicillin and isoniazid
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Recently reported biological activities of pyrazole compounds.
Topics: Analgesics; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; Antineoplastic Agents; Antiviral Agents; Humans; Pyrazoles | 2017 |
Benzofuran derivatives and their anti-tubercular, anti-bacterial activities.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Benzofurans; Humans; Structure-Activity Relationship | 2019 |
Principles of therapy.
Topics: Adrenal Cortex Hormones; Aerosols; Ampicillin; Animals; Atropine; Bronchodilator Agents; Chloramphenicol; Cromolyn Sodium; Horse Diseases; Horses; Isoniazid; Oxytetracycline; Penicillins; Pyrilamine; Respiratory Tract Diseases | 1979 |
[Treatment of central nervous system infections].
Topics: Adult; Aminosalicylic Acids; Ampicillin; Anti-Bacterial Agents; Bacteria; Brain Abscess; Chloramphenicol; Craniocerebral Trauma; Gentamicins; Humans; Infant, Newborn; Infant, Newborn, Diseases; Isoniazid; Meningitis; Meningitis, Haemophilus; Meningitis, Meningococcal; Meningitis, Pneumococcal; Meningitis, Viral; Penicillin G; Streptomycin; Tuberculosis, Meningeal | 1973 |
45 other study(ies) available for ampicillin and isoniazid
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Role of porins in the susceptibility of Mycobacterium smegmatis and Mycobacterium chelonae to aldehyde-based disinfectants and drugs.
Topics: Antitubercular Agents; Disinfectants; Drug Resistance, Bacterial; Glutaral; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Mycobacterium chelonae; Mycobacterium smegmatis; o-Phthalaldehyde; Porins | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Synthesis and evaluation of anti-tubercular activity of new dithiocarbamate sugar derivatives.
Topics: Antitubercular Agents; Carbohydrates; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxidoreductases; Thiocarbamates; Thioglucosides | 2011 |
Identification of novel potential antibiotics for tuberculosis by in silico structure-based drug screening.
Topics: Animals; Anti-Bacterial Agents; Cell Line; Cell Survival; Dogs; Drug Evaluation, Preclinical; Enoyl-(Acyl-Carrier-Protein) Reductase (NADH); Humans; Models, Molecular; Molecular Structure; Mycobacterium; Rhodococcus; Small Molecule Libraries; Stereoisomerism; Structure-Activity Relationship; Tuberculosis | 2011 |
Synthesis and identification of β-aryloxyquinolines and their pyrano[3,2-c]chromene derivatives as a new class of antimicrobial and antituberculosis agents.
Topics: Anti-Infective Agents; Aspergillus fumigatus; Bacteria; Benzopyrans; Candida albicans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Quinolines | 2011 |
1,3-Dihydro-2H-indol-2-ones derivatives: design, synthesis, in vitro antibacterial, antifungal and antitubercular study.
Topics: Antifungal Agents; Antitubercular Agents; Chemistry Techniques, Synthetic; Drug Design; Fungi; Indoles; Microbial Sensitivity Tests; Mycobacterium tuberculosis | 2011 |
Synthesis and evaluation of anti-tubercular and antibacterial activities of new 4-(2,6-dichlorobenzyloxy)phenyl thiazole, oxazole and imidazole derivatives. Part 2.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Bacteria; Bacterial Infections; Humans; Imidazoles; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazoles; Thiazoles; Tuberculosis | 2012 |
An improved microwave assisted one-pot synthesis, and biological investigations of some novel aryldiazenyl chromeno fused pyrrolidines.
Topics: Antifungal Agents; Antitubercular Agents; Aspergillus fumigatus; Azo Compounds; Benzopyrans; Candida albicans; Crystallography, X-Ray; Gram-Negative Bacteria; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Microwaves; Molecular Structure; Mycobacterium tuberculosis; Pyrrolidines; Stereoisomerism; Thiosemicarbazones | 2012 |
New N-arylamino biquinoline derivatives: synthesis, antimicrobial, antituberculosis, and antimalarial evaluation.
Topics: Antimalarials; Antitubercular Agents; Chemistry Techniques, Synthetic; Electrons; Fungi; Hydrophobic and Hydrophilic Interactions; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Plasmodium falciparum; Quinolines | 2012 |
Green synthesis and anti-infective activities of fluorinated pyrazoline derivatives.
Topics: Anti-Infective Agents; Antitubercular Agents; Bacteria; Bacterial Infections; Fungi; Green Chemistry Technology; Halogenation; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Mycoses; Pyrazoles; Tuberculosis | 2012 |
An efficient domino reaction in ionic liquid: synthesis and biological evaluation of some pyrano- and thiopyrano-fused heterocycles.
Topics: Aldehydes; Anti-Bacterial Agents; Coumarins; Gram-Negative Bacteria; Gram-Positive Bacteria; Heterocyclic Compounds; Ionic Liquids; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrans; Pyrazolones; Quinolines; Structure-Activity Relationship | 2013 |
Synthesis and identification of β-aryloxyquinoline based diversely fluorine substituted N-aryl quinolone derivatives as a new class of antimicrobial, antituberculosis and antioxidant agents.
Topics: Animals; Anti-Infective Agents; Antioxidants; Antitubercular Agents; Artemia; Aspergillus fumigatus; Candida albicans; Dose-Response Relationship, Drug; Fluorine; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Models, Chemical; Molecular Structure; Mycobacterium tuberculosis; Ovum; Quinolines; Structure-Activity Relationship | 2013 |
Design and synthesis of biquinolone-isoniazid hybrids as a new class of antitubercular and antimicrobial agents.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Antitubercular Agents; Artemia; Bacteria; Dose-Response Relationship, Drug; Drug Design; Fungi; Isoniazid; Microbial Sensitivity Tests; Molecular Structure; Motor Activity; Quinolones; Structure-Activity Relationship; Tuberculosis | 2013 |
New derivatives of salicylamides: Preparation and antimicrobial activity against various bacterial species.
Topics: Ampicillin; Anti-Infective Agents; Ciprofloxacin; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Salicylamides; Structure-Activity Relationship | 2013 |
Hytramycins V and I, anti-Mycobacterium tuberculosis hexapeptides from a Streptomyces hygroscopicus strain.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Chromatography, High Pressure Liquid; Inhibitory Concentration 50; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nuclear Magnetic Resonance, Biomolecular; Peptides, Cyclic; Streptomyces; Vero Cells | 2013 |
Synthesis, characterization and pharmacological screening of some novel 5-imidazopyrazole incorporated polyhydroquinoline derivatives.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Bacteria; Dose-Response Relationship, Drug; Fungi; Microbial Sensitivity Tests; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymers; Pyrazoles; Quinolines; Structure-Activity Relationship | 2014 |
Identification of 1-[4-Benzyloxyphenyl)-but-3-enyl]-1H-azoles as New Class of Antitubercular and Antimicrobial Agents.
Topics: | 2013 |
Ultrasound-assisted one-pot four-component synthesis of novel 2-amino-3-cyanopyridine derivatives bearing 5-imidazopyrazole scaffold and their biological broadcast.
Topics: Antioxidants; Antitubercular Agents; Chemistry Techniques, Synthetic; Fungi; Mycobacterium tuberculosis; Pyrazoles; Pyridines; Structure-Activity Relationship; Ultrasonics | 2014 |
Design, synthesis and characterization of fluoro substituted novel pyrazolylpyrazolines scaffold and their pharmacological screening.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Bacteria; Dose-Response Relationship, Drug; Drug Design; Fungi; Microbial Sensitivity Tests; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrazoles; Structure-Activity Relationship | 2014 |
Design, synthesis and 3D-QSAR studies of new diphenylamine containing 1,2,4-triazoles as potential antitubercular agents.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Chlorocebus aethiops; Diphenylamine; Dose-Response Relationship, Drug; Drug Design; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Molecular Structure; Quantitative Structure-Activity Relationship; Structure-Activity Relationship; Triazoles; Vero Cells | 2014 |
Synthesis, structure-activity relationship studies, and antibacterial evaluation of 4-chromanones and chalcones, as well as olympicin A and derivatives.
Topics: Animals; Anti-Bacterial Agents; Chalcones; Chemistry Techniques, Synthetic; Chlorocebus aethiops; Chromones; DNA Gyrase; DNA Topoisomerase IV; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Phloroglucinol; Structure-Activity Relationship; Topoisomerase II Inhibitors; Vero Cells | 2014 |
Novel morpholinoquinoline nucleus clubbed with pyrazoline scaffolds: Synthesis, antibacterial, antitubercular and antimalarial activities.
Topics: Anti-Infective Agents; Antimalarials; Antitubercular Agents; Bacteria; Bacterial Infections; Fungi; Humans; Malaria, Falciparum; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Mycoses; Plasmodium falciparum; Pyrazoles; Quinolines; Structure-Activity Relationship; Tuberculosis | 2016 |
Synthesis, biological evaluation and molecular docking study of some novel indole and pyridine based 1,3,4-oxadiazole derivatives as potential antitubercular agents.
Topics: Animals; Antitubercular Agents; Cell Line; Humans; Indoles; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium bovis; Mycobacterium tuberculosis; Oxadiazoles; Pyridines; Structure-Activity Relationship; Tuberculosis | 2016 |
Facile synthesis of 1,3-thiazolidin-4-ones as antitubercular agents.
Topics: Animals; Antitubercular Agents; Cell Line; Combinatorial Chemistry Techniques; Green Chemistry Technology; Humans; Microbial Sensitivity Tests; Mycobacterium bovis; Mycobacterium tuberculosis; Structure-Activity Relationship; Thiazolidines; Tuberculosis | 2016 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Synthesis, identification and in vitro biological evaluation of some novel quinoline incorporated 1,3-thiazinan-4-one derivatives.
Topics: Anti-Bacterial Agents; Antimalarials; Antitubercular Agents; Clostridium tetani; Gram-Negative Bacteria; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Plasmodium falciparum; Quinolines; Spectroscopy, Fourier Transform Infrared; Structure-Activity Relationship; Thiazines | 2017 |
QSAR-driven design, synthesis and discovery of potent chalcone derivatives with antitubercular activity.
Topics: Animals; Antitubercular Agents; Chalcone; Chlorocebus aethiops; Dose-Response Relationship, Drug; Drug Design; Drug Discovery; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Quantitative Structure-Activity Relationship; Tuberculosis, Multidrug-Resistant; Vero Cells | 2017 |
Design, synthesis and 2D QSAR study of novel pyridine and quinolone hydrazone derivatives as potential antimicrobial and antitubercular agents.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Cell Line; Dose-Response Relationship, Drug; Drug Design; Fibroblasts; Fungi; Humans; Hydrazones; Microbial Sensitivity Tests; Molecular Structure; Pyridines; Quantitative Structure-Activity Relationship; Quinolones | 2017 |
Synthesis, antimicrobial activity and acid dissociation constants of methyl 5,5-diphenyl-1-(thiazol-2-yl)pyrrolidine-2-carboxylate derivatives.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Cycloaddition Reaction; Dose-Response Relationship, Drug; Fungi; Microbial Sensitivity Tests; Molecular Structure; Pyrrolidines; Structure-Activity Relationship; Thiazoles | 2018 |
Structure based design, synthesis, and biological evaluation of imidazole derivatives targeting dihydropteroate synthase enzyme.
Topics: Anti-Bacterial Agents; Dihydropteroate Synthase; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Imidazoles; Ligands; Microbial Sensitivity Tests; Molecular Structure; Staphylococcus aureus; Structure-Activity Relationship; Vancomycin-Resistant Enterococci | 2021 |
Abnormal forms of bacteria produced by antibiotics.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteria; Cephalothin; Chloramphenicol; Escherichia coli; Gentamicins; Isoniazid; Klebsiella pneumoniae; Mycobacterium tuberculosis; Nalidixic Acid; Neisseria gonorrhoeae; Nitrofurantoin; Penicillins; Proteus mirabilis; Salmonella typhimurium; Staphylococcus aureus; Streptococcus pneumoniae; Tetracycline | 1975 |
The choice of systemic antimicrobial drugs.
Topics: Ampicillin; Anti-Infective Agents; Carbenicillin; Ethambutol; Gentamicins; Humans; Infant; Infant, Newborn; Injections, Intravenous; Injections, Spinal; Isoniazid; Meningitis; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Sepsis; Staining and Labeling; Tuberculosis; Urinary Tract Infections | 1971 |
[Drug monitoring in the medical ward of a regional hospital].
Topics: Adult; Ampicillin; Anticoagulants; Antidepressive Agents; Central Nervous System Stimulants; Chemical and Drug Induced Liver Injury; Digitalis Glycosides; Drug Eruptions; Drug Hypersensitivity; Drug Synergism; Female; Humans; Hypnotics and Sedatives; Isoniazid; Male; Middle Aged; Monitoring, Physiologic; Penicillins; Rifamycins; Sulfamethoxazole; Time Factors; Tranquilizing Agents; Trimethoprim | 1972 |
[Meningitis due to Listeria monocytogenes. Presentation of a case and literature review].
Topics: Adult; Amphotericin B; Ampicillin; Azathioprine; Cephaloridine; Cyclophosphamide; Female; Humans; Isoniazid; Listeria monocytogenes; Lupus Erythematosus, Systemic; Meningitis, Listeria; Prednisone; Streptomycin | 1973 |
Avian-induced hypersensitivity pneumonitis.
Topics: Adult; Allergens; Ampicillin; Animals; Arthus Reaction; Birds; Blood Gas Analysis; Diagnosis, Differential; Feathers; Female; Glucocorticoids; Humans; Hypersensitivity, Immediate; Immunodiffusion; Isoniazid; Lung; Male; Radiography; Respiratory Function Tests; Respiratory Hypersensitivity; Skin Tests; Streptomycin; Tetracycline; Tuberculin Test | 1972 |
Drug information: questions and answers.
Topics: Aged; Ampicillin; Contraceptives, Oral; Diuretics; Drug Hypersensitivity; Female; Food Analysis; Guanethidine; Humans; Isoniazid; Kidney Failure, Chronic; Male; Pharmaceutical Preparations; Photosensitivity Disorders; Potassium; Procaine; Rejuvenation; Sunscreening Agents; Tetracycline; Vitamin B Deficiency | 1974 |
Congenital tuberculosis: report of a case.
Topics: Adult; Ampicillin; Ethambutol; Female; Fever; Humans; Infant; Infant, Newborn; Isoniazid; Kanamycin; Pregnancy; Streptomycin; Tuberculosis, Female Genital; Tuberculosis, Miliary; Tuberculosis, Pulmonary | 1974 |
Development of sympathetic uveitis in spite of corticosteroid therapy.
Topics: Ampicillin; Choroid; Eye Injuries; Humans; Isoniazid; Male; Middle Aged; Ophthalmia, Sympathetic; Prednisone; Retina; Uvea; Uveitis | 1974 |
Giant cell arteritis and microangiopathic hemolytic anemia.
Topics: Aged; Ampicillin; Anemia, Hemolytic; Cyclophosphamide; Female; Giant Cell Arteritis; Humans; Isoniazid; Meningitis, Listeria; Prednisone; Pyridoxine | 1982 |
Bactericidal action of ofloxacin, sulbactam-ampicillin, rifampin, and isoniazid on logarithmic- and stationary-phase cultures of Mycobacterium tuberculosis.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Colony Count, Microbial; Drug Therapy, Combination; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Penicillins; Rifampin; Sulbactam | 1996 |
Bioactivity of Methoxylated and Methylated 1-Hydroxynaphthalene-2-Carboxanilides: Comparative Molecular Surface Analysis.
Topics: Ampicillin; Anilides; Anti-Bacterial Agents; Chloroplasts; Electron Transport; Humans; Isoniazid; Methicillin-Resistant Staphylococcus aureus; Methylation; Microbial Sensitivity Tests; Mycobacterium kansasii; Mycobacterium tuberculosis; Naphthols; Photosynthesis; Principal Component Analysis; Spinacia oleracea; Structure-Activity Relationship; THP-1 Cells | 2019 |
Study of Biological Activities and ADMET-Related Properties of Salicylanilide-Based Peptidomimetics.
Topics: Ampicillin; Anilides; Anti-Bacterial Agents; Benzamides; Humans; Isoniazid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Peptidomimetics; Salicylanilides; Vancomycin | 2022 |